Achilles Therapeutics plc
ACHL
$0.8037
$0.02373.04%
Headlines
4/28/2024
-
Zolmax
4/16/2024
-
Zolmax
4/7/2024
-
Zolmax
4/4/2024
-
The Fly
4/4/2024
-
The Fly
4/4/2024
-
The Fly
4/4/2024
-
InvestorPlace
4/4/2024
-
Seeking Alpha - Healthcare
4/4/2024
-
The Fly
4/4/2024
-
Globe Newswire
4/4/2024
-
The Fly
4/4/2024
-
Globe Newswire
4/4/2024
-
Ticker Report
2/26/2024
-
Simply Wall St
2/14/2024
-
Zolmax
2/12/2024
-
Ticker Report
2/9/2024
-
Zacks Investment Research
2/5/2024
-
Globe Newswire
1/26/2024
-
Zolmax
1/24/2024
-
Zacks Investment Research
1/19/2024
-
Zolmax
1/1/2024
-
Zolmax
Filings
Thursday, April 4, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
--
Corporate Info
44 20 8154 4600
245 Hammersmith Road
London, W6 8PW
London, W6 8PW
Business Description
Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The...
more